Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations.
Lawrence JA, Adamson PC, Caruso R, Chow C, Kleiner D, Murphy RF, Venzon DJ, Shovlin M, Noone M, Merino M, Cowan KH, Kaiser M, O'Shaughnessy J, Zujewski J.
Lawrence JA, et al. Among authors: adamson pc.
J Clin Oncol. 2001 May 15;19(10):2754-63. doi: 10.1200/JCO.2001.19.10.2754.
J Clin Oncol. 2001.
PMID: 11352969
Clinical Trial.